Will immunotherapy redefine terminal illness?
Contenido multimedia no disponible por derechos de autor o por acceso restringido. Contacte con la institución para más información.
| Tag | 1 | 2 | Valor |
|---|---|---|---|
| LDR | 00000cab a22000004b 4500 | ||
| 001 | MAP20160010503 | ||
| 003 | MAP | ||
| 005 | 20160331172700.0 | ||
| 008 | 160331e20160201gbr|| p |0|||b|eng d | ||
| 040 | $aMAP$bspa$dMAP | ||
| 084 | $a34 | ||
| 100 | 1 | $0MAPA20160004472$aBolshaw, Mike | |
| 245 | 1 | 0 | $aWill immunotherapy redefine terminal illness?$cMike Bolshaw |
| 520 | $aCancer treatments are working better, but the bad news is insurers may soon be paying terminal illness claims long before the death of the policyholder | ||
| 650 | 4 | $0MAPA20080624941$aSeguro de enfermedades graves | |
| 650 | 4 | $0MAPA20100048191$aEnfermedades terminales | |
| 650 | 4 | $0MAPA20080553630$aCoberturas | |
| 650 | 4 | $0MAPA20080540500$aCáncer | |
| 650 | 4 | $0MAPA20080587901$aSeguro de personas | |
| 773 | 0 | $tCovermagazine.co.uk$gFebruary 2016 ; p. 33-34 |